Publications by authors named "Hal Martin"

Claim this Profile
A
A finite element analysis model to support ligamentum teres function.
Yongni Zhang, Jianing Wang, Linxia Gu, Hal David Martin, RobRoy L Martin

J Hip Preserv Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence.
Kristen Andreatta, Michelle L D'Antoni, Silvia Chang, Aiyappa Parvangada, Ross Martin, Hal Martin

J Med Virol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predominant insertion of the ischiofemoral ligament is a merging to the iliofemoral ligament as demonstrated on magnetic resonance arthrogram studies.
Munif Hatem, Megan Badejo, Michael McCarroll, Richard Feng, Hal David Martin

Acta Radiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two 5-year studies of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: a plain-language summary.
Paul E Sax, Jason T Hindman, Hal Martin, David Wohl

Future Microbiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data.
Michelle L D'Antoni, Kristen Andreatta, Silvia Chang, Stephanie Cox, Jason T Hindman, Hal Martin

J Acquir Immune Defic Syndr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy.
Chloe Orkin, Andrea Antinori, Jürgen K Rockstroh, Santiago Moreno-Guillén, Claudia T Martorell, Hal Martin

AIDS· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial.
Anchalee Avihingsanon, Hongzhou Lu, Chee Loon Leong, Chien-Ching Hung, Ellen Koenig, Hal Martin

Lancet HIV· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.
Paul E Sax, José R Arribas, Chloe Orkin, Adriano Lazzarin, Anton Pozniak, Hal Martin

EClinicalMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.
Anchalee Avihingsanon, Ploenchan Chetchotisakd, Sasisopin Kiertiburanakul, Winai Ratanasuwan, Krittaecho Siripassorn, Hal Martin

HIV Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior Electronic Hip Pain Drawings Are Helpful for Diagnosis of Intra-articular Sources of Pain: Lateral or Posterior Drawings Are Unreliable.
Richard Feng, Munif Hatem, Hal David Martin

Arthrosc Sports Med Rehabil· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging changes following surgery for ischiofemoral impingement.
Munif Hatem, Richard Feng, Jordan Teel, Hal David Martin

Proc (Bayl Univ Med Cent)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
Franco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina, Federico Pulido, Stephane De Wit, Hal Martin

HIV Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.
Paul E Sax, Kristen Andreatta, Jean-Michel Molina, Eric S Daar, Debbie Hagins, Ross Martin, Hal Martin

AIDS· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hip physical examination extension loss and radiographic osseous findings in patients with low back pain and nonarthritic hips.
Richard Feng, Munif Hatem, Scott J Nimmons, Ashley Disantis, RobRoy L Martin, Hal David Martin

Proc (Bayl Univ Med Cent)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials.
Michelle L D'Antoni, Kristen Andreatta, Rima Acosta, Hal Martin, Silvia Chang, Ross Martin

J Acquir Immune Defic Syndr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
Kristine M Erlandson, Christoph C Carter, Kathleen Melbourne, Todd T Brown, Cal Cohen, Hal Martin

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial.
Aditya H Gaur, Mark F Cotton, Carina A Rodriguez, Eric J McGrath, Elizabeth Helström, Hal Martin

Lancet Child Adolesc Health· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
Debbie Hagins, Princy Kumar, Michael Saag, Anson K Wurapa, Indira Brar, Hal Martin

J Acquir Immune Defic Syndr· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iliopsoas Muscle/Tendon Proportions at Three Levels of Described Arthroscopic Tenotomy: An Anatomic Study in Fresh Cadaveric Specimens.
Juan Gómez-Hoyos, William H Márquez, Jaime A Gallo, Antony Khoury, Sofía Bernal-Sierra, Hal D Martin

Arthrosc Sports Med Rehabil· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of magnetic resonance imaging to diagnose greater trochanteric-ischial impingement.
Munif Hatem, Kathryn E Canavan, RobRoy L Martin, Jonathan Dawkins, Hal David Martin

Proc (Bayl Univ Med Cent)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2019 International Society of Hip Preservation (ISHA) physiotherapy agreement on assessment and treatment of femoroacetabular impingement syndrome (FAIS): an international consensus statement.
Amir Takla, John O'Donnell, Michael Voight, Thomas Byrd, Michael Dienst, Rob Roy Martin, Hal Martin

J Hip Preserv Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: The 2019 International Society of Hip Preservation (ISHA) physiotherapy agreement on assessment and treatment of femoroacetabular impingement syndrome (FAIS): an international consensus statement.
Amir Takla, John O'Donnell, Michael Voight, Thomas Byrd, Michael Dienst, Rob Roy Martin, Hal Martin

J Hip Preserv Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hip-spine syndrome: rationale for ischiofemoral impingement, femoroacetabular impingement and abnormal femoral torsion leading to low back pain.
Anthony N Khoury, Munif Hatem, Joshua Bowler, Hal David Martin

J Hip Preserv Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain management practice patterns after hip arthroscopy: an international survey.
Flávio L Garcia, Brady T Williams, Bhargavi Maheshwer, Asheesh Bedi, Ivan H Wong, Hal D Martin

J Hip Preserv Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biomechanical analysis of ischiofemoral impingement in a cadaver model.
Yoichi Murata, Naomasa Fukase, Hajime Utsunomiya, Alex W Brady, Samuel I Rosenberg, Hal David Martin

J Hip Preserv Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis